Bluefin Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-6,233	Closed	-$240K	–	504
2014 Q3	$240K	Buy	+6,233	New	+$240K	0.01%	392
2014 Q2	–	Hold	0	–	–	–	549